Nonsense-mediated RNA decay: an emerging modulator of malignancy is a research paper published in Nature Reviews Cancer (2022). On theSindex it has a DataRank of 0.753. It has been cited 150 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.753
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: R01 CA244182
NCI NIH HHS
Grant: R01 CA247562
NICHD NIH HHS
Grant: R01 HD093846
National Institutes of Health
Grant: 5R01CA244182-03
FOXL2 in Adult Granulosa Cell Tumorigenesis
National Institutes of Health
Grant: 1R01CA247562-01
Dissecting FAK-regulated oncogenic signaling programs in ovarian cancer
National Institutes of Health
Grant: 5R01HD093846-05
The Role of NMD in Embryonic Development
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of Comprehensive analysis of neoantigens derived from structural variation across whole genomes from 2528 tumors
Additional file 2 of Comprehensive analysis of neoantigens derived from structural variation across whole genomes from 2528 tumors
Additional file 3 of Comprehensive analysis of neoantigens derived from structural variation across whole genomes from 2528 tumors
Additional file 3 of Comprehensive analysis of neoantigens derived from structural variation across whole genomes from 2528 tumors
Additional file 1 of Comprehensive analysis of neoantigens derived from structural variation across whole genomes from 2528 tumors
Additional file 1 of Comprehensive analysis of neoantigens derived from structural variation across whole genomes from 2528 tumors